Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma
Clinical trial NCT06530823 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06530823
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-08-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.